Feed INBX
IN
Inhibrx Biosciences Inc.
INBX · NASDAQ
$85.92 -0.21% (-$0.18)
1M -6.33%
Market Cap $1.3B
P/E Ratio -
Div. Yield -
ROE 269.56%
Bulios Fair Price
$117.81
37.1% upside
Τρέχουσα τιμή
$85.92
Υποτιμημένο Δίκαιη αξία Υπερτιμημένο
Valuation
0 /100
Expensive P/S 988.73x
P/B 160.81x
P/E N/A
Growth
0 /100
Declining Rev. growth 15.98%
Book val. growth 48.36%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 0.00%
Net margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor ROIC 0.00%
ROE 0.00%
Asset turnover 0.01x
Debt
70 /100
Low Debt/Equity 12.58x
Current ratio 3.68x
Net debt/EBITDA 0.19x
Stability
1 /100
Unstable Beta 3.43x
Rev. volatility 350.17%
Profitable years 0
Ρωτήστε το StockBot για INBX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark Lappe
Employees
109
Headquarters
La Jolla
Επερχόμενα γεγονότα
12 ΑΥΓ
Earnings
Upcoming earnings report